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Patients with obstructive sleep apnoea (OSA) frequently present symptoms of
depression, anxiety and insomnia and continuous positive airway pressure (CPAP)
can improve these symptoms. Using a real-world administrative database, we
analysed the trend of psychotropic drug use (antidepressants, anxiolytics and
hypnotics) on a long-term period in OSA individuals before-after CPAP initiation. A
total of 869 OSA individuals to whom psychotropic drugs were prescribed were
followed for 4 years. They were matched to 2,607 non-OSA individuals, who were
similar in terms of demographics, chronic diseases and care consumption.
Generalized estimating equations models were used to compare psychotropic drug
defined daily doses (DDD). Results showed no significant differences in mean trends
of psychotropic drug DDD between OSA individuals and non-OSA matched controls
during the three years following CPAP initiation. Only time had a significant effect
on DDD, which decreased in both groups: −9% in Y1 and −17% in Y3, compared to
Y0 (p-values < 0.0001). Hence, CPAP therapy does not result in an earlier decrease
of psychotropic drug use in OSA individuals compared to non-OSA matched controls.
Further studies are needed to analyse long-term psychotropic drug use, particularly
in non-adherent OSA individuals.
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